omega-N-Methylarginine
Showing 26 - 50 of 8,561
Obesity, Insulin Resistance Trial in Scottsdale (Insulin, NG-monomethyl-L-arginine)
Completed
- Obesity
- Insulin Resistance
-
Scottsdale, ArizonaMayo Clinic in Arizona
Oct 1, 2021
Chronic Pain Following Thermal Burn Injury Trial in Chapel Hill (Omega-3 fatty acids (fish oil), Vitamin D3 (cholecalciferol),
Terminated
- Chronic Pain Following Thermal Burn Injury
- Omega-3 fatty acids (fish oil)
- +3 more
-
Chapel Hill, North CarolinaUniversity Of North Carolina
Jul 23, 2021
Diabetes Trial in Oxford (Aspirin, Omega-3 Ethyl Esters, Placebo Aspirin)
Active, not recruiting
- Diabetes Mellitus
- Aspirin
- +3 more
-
Oxford, United KingdomClinical Trial Service Unit, NDPH, University of Oxford
Jun 17, 2021
Cognitive Impairment, Depression Trial in Guanzhou (Experimental group of n-pufas improving cognitive formula, General fish oil
Recruiting
- Cognitive Impairment
- Depression
- Experimental group of n-pufas improving cognitive formula
- +2 more
-
Guanzhou, Guangdong, ChinaGuangzhou Brain Hospital (Guangzhou Huiai Hospital)
Mar 15, 2021
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)
Active, not recruiting
- Stage IA Breast Cancer
- +6 more
- Omega-3 fatty acid
- Celecoxib
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 14, 2022
Arthralgia, Breast Tumors Trial in Duarte, Cleveland, Columbus (Omega-3 Fatty Acid, Placebo)
Recruiting
- Arthralgia
- Breast Neoplasms
- Omega-3 Fatty Acid
- Placebo
-
Duarte, California
- +2 more
Jan 14, 2021
Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)
Not yet recruiting
- Alcohol Use Disorder, Severe
- Active Comparator: Omega-3
- Placebo Comparator: olive oil
- (no location specified)
Jun 1, 2023
Psychosis Trial in Canada, United States (Omega-3 Long Chain Fatty Acid, Placebo)
Completed
- Psychosis
- Omega-3 Long Chain Fatty Acid
- Placebo
-
Los Angeles, California
- +8 more
Feb 3, 2021
Non-Muscle Invasive Bladder Cancer Trial in Mansoura (n-3PUFAs Treatment, Placebo Treatment)
Recruiting
- Non-Muscle Invasive Bladder Cancer
- n-3PUFAs Treatment
- Placebo Treatment
-
Mansoura, EgyptUrology and Nephrology Center, Mansoura University
Dec 17, 2020
Obesity Trial in Guadalajara (n-3 supplementation group, Placebo group)
Completed
- Obesity
- n-3 supplementation group
- Placebo group
-
Guadalajara, Jaliscco, Mexico
- +1 more
May 25, 2021
Coronary Artery Disease Trial in Ankara (Omega-3 fatty acid supplementation)
Completed
- Coronary Artery Disease
- Omega-3 fatty acid supplementation
-
Ankara, TurkeyGazi University Training and Research Hospital
Dec 14, 2022
Arthritis, Rheumatoid Trial in Rancagua (Placebo, Omega-3, Aerobic exercise)
Active, not recruiting
- Arthritis, Rheumatoid
- Placebo
- +2 more
-
Rancagua, Libertador Bernardo O'Higgins, ChileUniversidad de O'Higgins
Jul 11, 2023
Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma
Completed
- Plasma Omega-3 Status
-
Glasgow, United Kingdom
- +4 more
Jul 4, 2021
Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions Trial in Canada (DHA-rich algal oil, Placebo)
Active, not recruiting
- Bronchopulmonary Dysplasia
- +2 more
- DHA-rich algal oil
- Placebo
-
Calgary, Alberta, Canada
- +15 more
Jul 9, 2021
Eating Disorder Trial in Hamilton (Omega-3 Fatty Acid Supplement)
Completed
- Eating Disorder
- Omega-3 Fatty Acid Supplement
-
Hamilton, Ontario, CanadaMcMaster Children's Hospital
Dec 18, 2020
Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- behavioral dietary intervention
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Apr 4, 2022
Sarcopenia Trial in Cordoba (omega-3, Standard)
Recruiting
- Sarcopenia
- omega-3
- Standard
-
Cordoba, SpainIMIBIC
Aug 23, 2023
Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)
Recruiting
- Hypertriglyceridemia
- DHA-NAT
- Placebo
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Jul 11, 2023
Age Related Cognitive Decline, Alzheimer's Disease, Vascular Dementia Trial in Portland (Omega 3 PUFA, Placebo)
Active, not recruiting
- Age Related Cognitive Decline
- +4 more
- Omega 3 PUFA
- Placebo
-
Portland, OregonOregon Health & Science University
Sep 2, 2020
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia Trial in Tbilisi (Omega device)
Recruiting
- Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia
- Omega device
-
Tbilisi, Georgia
- +1 more
Mar 8, 2023
Depression Trial in Guangzhou (omega-3, )
Enrolling by invitation
- Depression
- omega-3
- placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Jul 11, 2023
Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)
Not yet recruiting
- Cardiovascular Risk
- Plant Omega
- Dietary therapy only
-
Petaling Jaya, Selangor, MalaysiaBeacon Hospital Sdn Bhd
May 21, 2023
Hypertriglyceridemia Trial in Tehran (Control, Omega-3 supplementation, Chia seed)
Not yet recruiting
- Hypertriglyceridemia
- Control
- +2 more
-
Tehran, Iran, Islamic Republic ofClinical Nutrition Research Unit, National Nutrition and Food Te
Sep 3, 2023
Autism Spectrum Disorders, Hyperactivity Trial in Multiple Locations (Omega-3 Fatty Acids, Placebo)
Completed
- Autism Spectrum Disorders
- Hyperactivity
- Omega-3 Fatty Acids
- Placebo
-
Multiple Locations, MarylandThis study is open to continental USA
Aug 17, 2020
Metastatic Triple Negative Breast Cancer Trial in Houston (L-NMMA, Docetaxel, Amlodipine)
Completed
- Metastatic Triple Negative Breast Cancer
- L-NMMA
- +4 more
-
Houston, TexasHouston Methodist Hospital
Oct 12, 2021